Loyal
PrivateLast Round
Series C
Feb 11, 2026
Est. Valuation
$425M
Total Funding Raised
$205M
Momentum
Top 25%
of companies Caplight tracks
Company Overview
Loyal operates in Healthcare & Life Sciences and is based in San Francisco, California. Its latest recorded funding round was a Series C round in February 2026.
Loyal is a clinical-stage veterinary medicine company that develops drugs intended to extend the healthspan and lifespan of dogs by delaying the onset of age-related diseases.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Clinical Trials
Business Model
B2B2C
Customer Profile
Subscription SaaS
AI Layer
Non-AI
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Loyal Comparables
Compare Loyal with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Rejuvenate Bio | 79% | |
| Gallant | 76% | |
| Anivive Lifesciences | 73% |
For institutional investors. Book with your work email.
Loyal Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series C | Feb 11, 2026 | ||||
| Series B Extension | Feb 26, 2025 | ||||
| Series B | Mar 21, 2024 | ||||
| Series A | Sep 23, 2021 | ||||
| Seed | Jan 1, 2020 |
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
Loyal Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Bain Capital Ventures | Series B Extension, Series B |
| Khosla Ventures | Series B, Seed, Series B Extension, Series A |
| Gaingels | Series A |
| age1 | Series C |
| Todd & Rahul Capital | Series B |
| Collaborative Fund | Series B, Series A, Seed, Series B Extension |
| First Round Capital | Series B, Series A, Seed, Series B Extension |
For institutional investors. Book with your work email.
Market signals
Structured signals derived from secondary market and firmographic data.
- Jun 21, 2026
Monthly visitors increased 45% MoM.
- Feb 11, 2026
$100M round raised.
For institutional investors. Book with your work email.
Recent news
Latest coverage and updates
- is_developingOct 18, 2026
Loyal is developing three drugs to help dogs live longer, including LOY-002, a daily pill for senior dogs tested in about 1,300 dogs across the United States; the company expects to apply for conditional approval in 2027.
- is_developingOct 16, 2026
Loyal is developing potential longevity drugs aimed at improving pets’ health and lifespan and conducts metabolic-health trials involving over 1,300 dogs in the United States.
- is_developingAug 29, 2026
Loyal is developing the first FDA-approved longevity and lifespan-extension drugs for dogs.
For institutional investors. Book with your work email.
Loyal Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Loyal's valuation, stock price, and market status.
Is Loyal a public or private company?
Loyal is a private company.
What is the current stock price of Loyal?
Loyal is a private company, so its shares have no public market price. Caplight tracks Loyal's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Loyal worth (valuation)?
Loyal's valuation is estimated at $425.0M based on funding round data.
Can I buy Loyal stock?
Loyal shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Loyal's last funding round?
Loyal's most recent funding round was Series C on February 11, 2026.
Who are the main investors in Loyal?
Key investors in Loyal include Bain Capital Ventures, Khosla Ventures, age1, Collaborative Fund, Valor Equity Partners.
Will Loyal IPO soon?
No public IPO plans have been announced for Loyal.
How can I track Loyal secondary market activity?
Caplight tracks bids, offers, and trades in Loyal's shares on secondary markets.